Sublingual Acute Stroke Neuroprotectant Dazzles in Phase III Trial
(MedPage Today) -- For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE-SL trial from China.
The...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Brain | Cardiology | Cardiovascular | China Health | Heart | Ischemic Stroke | Neurology | Stroke